Key result
Preoperative HbA1c over 7% is linked to ~56% higher all-cause mortality after CABG.
Why the study?
Does higher preoperative HbA1c level increase adverse clinical outcomes in diabetic patients undergoing CABG surgery?
Meta-Analysis (n=7,895)
Yes
Does higher preoperative HbA1c level increase adverse clinical outcomes in diabetic patients undergoing CABG surgery?
Preoperative HbA1c >7% is a significant predictor of mortality, MI, and stroke in diabetic patients undergoing CABG, supporting the importance of long-term glycemic control prior to revascularization.
Answers are grounded in this paper and cite their sources.
Higher preoperative HbA1c may stratify mortality risk in diabetic CABG patients; extends observational meta-analyses but leaves causal benefit open.
AIMS/INTRODUCTION: The aim of the present study was to investigate whether HbA1c was related to clinical outcomes in diabetic patients undergoing CABG surgery. MATERIALS AND METHODS: A literature search was carried out satisfying the predefined inclusion criteria from Pubmed, Embase, and Cochrane Library. Differences were expressed as odds ratios (ORs) with 95% confidence intervals (CIs) to assess the relationships of preoperative HbA1c levels and clinical prognosis in diabetic patients. RESULTS: 7895 diabetic patients undergoing CABG surgery from eight published studies were finally involved in this meta-analysis. Combined analyses revealed that the higher HbA1c level was significantly associated with increased risks of all-cause mortality (OR 1.56, 95%CI 1.29-1.88), myocardial infarction (OR 2.37, 95%CI 1.21-4.64), and stroke (OR 2.07, 95%CI 1.29-3.32) after CABG surgery. However, there was no significant relationship between HbA1c levels and renal failure (OR 2.08, 95%CI 0.96-4.54) in diabetic patients undergoing CABG surgery. CONCLUSIONS: Our meta-analysis demonstrated that the HbA1c level is potentially associated with increased risks of all-cause mortality, myocardial infarction, and stroke in diabetic subjects undergoing CABG surgery. However, further clinical studies with larger sample sizes and longer follow-up period are urgently warranted.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2017) conducted a meta-analysis in Diabetes mellitus undergoing CABG surgery (n=7,895). Higher preoperative HbA1c level vs. Optimal glycemic control (HbA1c ≤ 7% or similar threshold) was evaluated on All-cause mortality (OR 1.56, 95% CI 1.29-1.88, p=<0.001). Higher preoperative HbA1c levels (>7%) were significantly associated with an increased risk of all-cause mortality (OR 1.56) in diabetic patients undergoing CABG surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: